New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
aTyr Pharma, Inc. (ATYR) vs Lexaria Bioscience Corp. (LEXX)
- aTyr Pharma, Inc. ATYR 3.82 +3.52%
- Lexaria Bioscience Corp. LEXX 4.03 −10.24%
aTyr Pharma, Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. aTyr Pharma, Inc. and Lexaria Bioscience Corp. are of similar size ($9.5M and $9.0M). aTyr Pharma, Inc. has the higher net margin (−155.2% vs −1,686.1%) and the higher return on invested capital (0.00% vs −662.6%). Across the 16 metrics below, aTyr Pharma, Inc. leads on 11 and Lexaria Bioscience Corp. on 5.
Valuation
Profitability
| Metric | ATYR | LEXX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 99.62% | 70.18% |
| Operating margin | (152.19%) | (1,683.06%) | 0.00% |
| Net margin | (155.18%) | (1,686.05%) | 0.00% |
| Free cash flow margin | (148.11%) | (1,494.56%) | 0.00% |
| Return on equity | (93.69%) | (162.60%) | (51.58%) |
| Return on assets | (64.07%) | (134.20%) | (45.91%) |
| Return on invested capital | 0.00% | (662.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack